A18.82 Tuberculosis of other endocrine glands

Name of the Condition

• Tuberculosis of other endocrine glands
• ICD Code: A18.82

Summary

Tuberculosis of other endocrine glands is a form of extrapulmonary tuberculosis where Mycobacterium tuberculosis infects endocrine glands outside the thyroid, such as the adrenal glands, pancreas, or pituitary gland. This condition occurs when TB bacteria spread from a primary site, typically the lungs, to these glands via the bloodstream or lymphatic system. It may present with gland-specific symptoms or systemic effects, depending on the extent of infection and tissue involvement.

Causes

Tuberculosis of other endocrine glands is caused by the dissemination of Mycobacterium tuberculosis from an existing infection, usually pulmonary tuberculosis. The bacteria can travel to endocrine glands during active disease or reactivation of latent TB. Direct inoculation is rare but possible in certain cases.

Risk Factors

• Immunocompromised states, such as HIV/AIDS or chronic steroid use.
• History of untreated or inadequately treated tuberculosis.
• Close contact with individuals who have active TB.
• Living in or traveling to regions with high TB prevalence.
• Underlying conditions like diabetes or malnutrition.

Symptoms

• Gland-specific symptoms, such as adrenal insufficiency (e.g., fatigue, weight loss) or pancreatic dysfunction (e.g., diabetes-like symptoms).
• Systemic signs of infection, including fever, night sweats, or weight loss.
• Symptoms may vary based on the affected gland and its role in hormone production.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., CT or MRI) to identify gland abnormalities, and laboratory tests. Biopsy of the affected gland with histopathological examination and culture for Mycobacterium tuberculosis is often required to confirm the diagnosis. Additional tests, such as hormone level assessments, may be performed to evaluate gland function.

Treatment Options

Treatment typically follows standard antitubercular therapy regimens, including a combination of antibiotics (e.g., isoniazid, rifampin, pyrazinamide, and ethambutol) for a specified duration. Corticosteroids may be used in cases of adrenal insufficiency or severe inflammation. Management of gland-specific dysfunction (e.g., hormone replacement) may be necessary depending on the extent of damage.

Prognosis and Follow-Up

Prognosis depends on early diagnosis, timely treatment, and the extent of gland involvement. With appropriate therapy, most patients recover fully, but some may experience long-term gland dysfunction. Follow-up care includes monitoring for treatment response, assessing hormone levels, and ensuring completion of the full course of antibiotics to prevent recurrence.

Complications

• Permanent endocrine gland dysfunction (e.g., adrenal insufficiency, diabetes).
• Spread of infection to other organs.
• Treatment-related side effects from antitubercular medications.

Lifestyle & Prevention

• Adhere to prescribed treatment regimens to prevent drug resistance.
• Maintain a healthy lifestyle to support immune function.
• Avoid exposure to individuals with active TB in high-prevalence areas.
• Seek prompt medical care for symptoms of TB or endocrine dysfunction.

When to Seek Professional Help

• Persistent symptoms of infection (e.g., fever, night sweats, weight loss).
• New or worsening gland-specific symptoms (e.g., fatigue, hormonal imbalances).
• Signs of treatment failure or adverse drug reactions.

Tips for Medical Coders

• Use A18.82 for tuberculosis of endocrine glands other than the thyroid (e.g., adrenal, pancreas, pituitary).
• Ensure documentation specifies the affected gland(s) and confirms extrapulmonary TB involvement.
• Differentiate from other endocrine conditions or primary gland diseases to avoid miscoding.
• Verify that the diagnosis aligns with clinical findings and laboratory results.